title: [Sensitivity of patients to immunomodulators in immunodeficiency diseases].
abstract: There were examined 198 patients, in whom immunodeficient (inflammatory, infectious and viral) diseases were revealed, as well as 10 healthy persons--for investigation of sensitivity of the blood neutrophils to immunomodulators (timalin, immunofan, polyoxidonium, timogen, erbisol). Most active one, in accordance to the investigation data, have evolved a synthetic preparation polyoxidonium, action mechanism of which is caused by direct activating impact on phagocytosis. Absence of sensitivity of the blood neutrophils towards activating stimuli (immunomodulators) in some patients was caused by a phenomenon, according to which the blood neutrophils, persisting durably in a preactivated state, further (while examining of the patients) have a reduced capacity for answering to stimulation. Such factors, as persisting in organism components of cellular wall of microorganisms or viruses, as well as antiinflammatory citokines, which are secreted in answer to the infectious agent introduction, are altogether promote the blood neutrophils preactivated state persistence. In patients, suffering viral infections, the blood neutrophils are mostly sensitive to immunofan and timalin. Immunologic preparations must be selected individually, taking into account the data of tests for sensitivity.
authors.forename: A A
authors.initials: AA
authors.lastname: Stasenko
authors.forename: V V
authors.initials: VV
authors.lastname: Zhulaĭ
authors.forename: I Iu
authors.initials: IIu
authors.lastname: Novopol'tseva
authors.forename: L S
authors.initials: LS
authors.lastname: Dontsova
authors.forename: N V
authors.initials: NV
authors.lastname: Zaiats
authors.forename: V I
authors.initials: VI
authors.lastname: Negievich
mesh_terms: D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D007167:Immunotherapy / Q000379:methods*; D009504:Neutrophils / Q000187:drug effects / Q000276:immunology; D010587:Phagocytosis / Q000187:drug effects / Q000276:immunology; D057285:Precision Medicine
chemical_list: D007155:Immunologic Factors